Jonas Nilsson1, Mikael Källman2, Ulrika Östlund3, Georg Holgersson4, Michael Bergqvist5, Stefan Bergström4. 1. Centre for Research and Development, Gavle University Hospital, Gavle, Sweden Department of Radiation Sciences and Oncology, Umea University Hospital, Umea, Sweden Department of Radiology, Gavle University Hospital, Gavle, Sweden Jonas.Nilsson@regiongavleborg.se. 2. Department of Oncology, Gavle University Hospital, Gavle, Sweden. 3. Centre for Research and Development, Gavle University Hospital, Gavle, Sweden. 4. Centre for Research and Development, Gavle University Hospital, Gavle, Sweden Department of Oncology, Gavle University Hospital, Gavle, Sweden. 5. Centre for Research and Development, Gavle University Hospital, Gavle, Sweden Department of Oncology, Gavle University Hospital, Gavle, Sweden Department of Radiation Sciences and Oncology, Umea University Hospital, Umea, Sweden.
Abstract
BACKGROUND: Complementary alternative medicine (CAM) is widely used among patients with cancer. This usage may have potentially harmful effects, especially when combined with anticancer drugs. However, some complementary methods may benefit patients. This review investigated the prevalence of CAM use among patients with cancer in Scandinavia and secondly studied the educational levels of CAM users compared to non-users. MATERIALS AND METHODS: A systematic search of the PubMed library was carried out to locate articles published between January 2000 and October 2015 that investigated prevalence of CAM use among Scandinavian patients with cancer. RESULTS: Twenty-two articles were found, of which nine were included in the review. The prevalence of CAM use was 7.9% to 53%, with an average of 36.0% across all studies. CONCLUSION: Use of CAM is widespread among patients with cancer. Knowledge about CAM should be disseminated to both patients and staff in order to optimise discussions about CAM in clinical practice. Copyright
BACKGROUND: Complementary alternative medicine (CAM) is widely used among patients with cancer. This usage may have potentially harmful effects, especially when combined with anticancer drugs. However, some complementary methods may benefit patients. This review investigated the prevalence of CAM use among patients with cancer in Scandinavia and secondly studied the educational levels of CAM users compared to non-users. MATERIALS AND METHODS: A systematic search of the PubMed library was carried out to locate articles published between January 2000 and October 2015 that investigated prevalence of CAM use among Scandinavian patients with cancer. RESULTS: Twenty-two articles were found, of which nine were included in the review. The prevalence of CAM use was 7.9% to 53%, with an average of 36.0% across all studies. CONCLUSION: Use of CAM is widespread among patients with cancer. Knowledge about CAM should be disseminated to both patients and staff in order to optimise discussions about CAM in clinical practice. Copyright
Authors: Christian Keinki; Emadaldin Ahmadi; Karin Kastrati; Bijan Zomorodbakhsch; Jutta Hübner Journal: In Vivo Date: 2022 Sep-Oct Impact factor: 2.406
Authors: Kirsti I Toivonen; Rie Tamagawa; Michael Speca; Joanne Stephen; Linda E Carlson Journal: Integr Cancer Ther Date: 2018-01-24 Impact factor: 3.279
Authors: Agnete E Kristoffersen; Jorunn V Nilsen; Trine Stub; Johanna Hök Nordberg; Barbara Wider; Dana Mora; Kiwumulo Nakandi; Mona Bjelland Journal: BMC Complement Med Ther Date: 2022-07-29
Authors: Agnete Egilsdatter Kristoffersen; Miek C Jong; Johanna Hök Nordberg; Esther T van der Werf; Trine Stub Journal: BMC Complement Med Ther Date: 2022-09-03